Bronchiectasis Treatment
Links shared publicly online about this topic
What Are The Treatment Options For Bronchiectasis (Bronchiectasia)?
medicalnewstoday.com — “Bronchiectasis, also known as bronchiectasia, is incurable. Treatment focuses on controlling infections and secretions, relieving obstructions in the airway, sometimes surgically rem” View full resource at medicalnewstoday.com
Most Recently Shared on April 17, 2010 at 4:05 pm By:
What Are The Treatment Options For Bronchiectasis (Bronchiectasia)? http://mnt.to/3Bph #asthma
Surgery Medical News about Bronchiectasis
mdlinx.com — “Surgical Treatment of Bronchiectasis: A Retrospective Analysis of 790 Patients” View full resource at mdlinx.com
Most Recently Shared on June 30, 2010 at 11:58 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Surgical Treatment of Bronchiectasis: A Retrospective Analysis of 790 Patients: Annals of Thoracic Surgery http://bit.ly/cTKxxH #SURG
Bronchiectasis Symptoms, Treatment, and Prognosis by MedicineNet.com
medicinenet.com — “Learn about bronchiectasis (a lung condition) symptoms like recurrent cough, sputum production, and shortness of breath. Causes of bronchiectasis can be acquired (infections, drug abuse, alcohol abuse, IBD) or congenital (cystic fibrosis)” View full resource at medicinenet.com
Most Recently Shared on May 24, 2010 at 11:42 pm By:
MedicineNet: Bronchiectasis http://bit.ly/d6xZsJ Full http://bit.ly/becmM7
Aradigm Reports Successful ORBIT-1 Bronchiectasis Study With Inhaled Liposomal Ciprofloxacin
medicalnewstoday.com — “Aradigm Corporation (OTCBB:ARDM) (the Company) today announced positive top line data from its recently concluded Phase 2b study (Once-Daily Respiratory Bronchiectasis Inhalation Treatment - ORB” View full resource at medicalnewstoday.com
Most Recently Shared on June 17, 2011 at 4:05 pm By:
MNT Cystic Fibrosis Health News
Aradigm Reports Successful ORBIT-1 Bronchiectasis Study With Inhaled Liposomal Ciprofloxacin http://mnt.to/3Xmt #cysticfibrosis
Phase 2 study of Arikace for the treatment of non-cystic fibrosis (CF) bronchiectasis - MPR
empr.com — “Transave reported positive results from its Phase 2 trial in non-cystic fibrosis (CF) bronchiectasis patients for its lead investigational drug, Arikace (liposomal amikacin for inhalation).” View full resource at empr.com
Most Recently Shared on September 14, 2009 at 5:43 pm By:
MPR News: Phase 2 study of Arikace for the treatment of non-cystic fibrosis (CF) bronchiectasis: Transa.. http://bit.ly/4lcuVY
Aradigm Doses First Patient In Its Second Phase 2b Clinical Trial Of Inhaled Liposomal Ciprofloxacin In Bronchiectasis Patients
medicalnewstoday.com — “Aradigm Corporation (OTCBB:ARDM) (the Company) announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an” View full resource at medicalnewstoday.com
Most Recently Shared on February 25, 2010 at 3:07 pm By:
Aradigm Doses First Patient In Its Second Phase 2b Clinical Trial Of Inhaled Liposomal Ciprofloxacin In Bronchiectasis... http://mnt.to/3y6r
Enrollment complete in Aradigm's inhaled ciprofloxacin Phase 2b study in non-cystic fibrosis bronchiectasis
news-medical.net — “Aradigm Corporation announced the last patient was enrolled in a Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (CFI, ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE), a severe progressive respiratory disease for which there is currently no approved treatment in the U.S.” View full resource at news-medical.net
Most Recently Shared on March 23, 2011 at 4:49 am By:
Enrollment complete in Aradigm's inhaled ciprofloxacin Phase 2b study in non-cystic fibrosis bronchiectasis: Ara... http://bit.ly/hMkIse
Aradigm demonstrates top line data from ORBIT-1 ARD-3100 Phase 2b study for bronchiectasis
news-medical.net — “Aradigm Corporation today announced positive top line data from its recently concluded Phase 2b study (Once-Daily Respiratory Bronchiectasis Inhalation Treatment - ORBIT-1) with Aradigm's ciprofloxacin for inhalation (CFI, ARD-3100, LipoquinTM) in patients with non-cystic fibrosis bronchiectasis (BE).” View full resource at news-medical.net
Most Recently Shared on June 16, 2011 at 1:40 pm By:
Aradigm demonstrates top line data from ORBIT-1 ARD-3100 Phase 2b study for bronchiectasis: Aradigm Corporation ... http://bit.ly/m6m5x4
Aradigm initiates dosing in Phase 2b trial of inhaled liposomal ciprofloxacin formulations in BE patients
news-medical.net — “Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no” View full resource at news-medical.net
Most Recently Shared on February 23, 2010 at 1:32 pm By:
Aradigm initiates dosing in Phase 2b trial of inhaled liposomal ciprofloxacin formulations in BE patients: Aradigm... http://bit.ly/abhAXg
COPD (Chronic Obstructive Pulmonary Disease) Symptoms, Causes, and Treatments by MedicineNet.com
medicinenet.com — “Learn about copd (chronic obstructive pulmonary disease) symptoms such as chronic cough, shortness of breath, and frequent respiratory infections. emphysema, smoking, and chronic bronchitis symptoms may be more complicated.” View full resource at medicinenet.com
Most Recently Shared on December 19, 2009 at 8:31 am By:
MedicineNet: Chronic Obstructive Pulmonary Disease http://bit.ly/58UwN0 Full http://bit.ly/5rqBcp
Chronic Obstructive Pulmonary Disease and Emphysema: eMedicine Emergency Medicine
emedicine.medscape.com — “Overview: Chronic obstructive pulmonary disease (COPD) is estimated to affect 32 million persons in the United States and is the fourth leading cause of death in this country. Patients typically have symptoms of both chronic bronchitis and ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 30, 2010 at 4:14 am By:
Susan Scroggins Health Advocate and Active Health Library
COPD is estimated to affect 32 million people in the US. Most patients suffer from chronic bronchitis & emphysema. http://bit.ly/bL4BaZ
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Asthma News
The latest asthma and respiratory news published daily. Articles from research centers, universities and prestigious journals.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Heart Health
Get the latest news, information, and research on your heart. Re-tweet if you want.
Advertisement
